"Opened in 1992, The Kirklin Clinic of UAB Hospital is a specially designed "superclinic" for outpatient medical care, housing hundreds of physicians in nearly three dozen specialties. Today, The Kirklin Clinic of UAB Hospital is one of the busiest outpatient centers in America and is renowned for providing the most advanced health care services that are both compassionate and convenient for our patients and their families."

During the past decade, The Kirklin Clinic conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 26 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 18 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Kirklin Clinic" #1 sponsor was "University of Alabama at Birmingham" with 20 trials, followed by "Pfizer" with 11 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored, "Novartis Pharmaceuticals" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Kirklin Clinic" #1 collaborator was "Allergan" with 2 trials as a collaborator, "Abbott Nutrition" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bracco Corporate" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "The Kirklin Clinic" are "Psoriasis" (4 trials), "Breast Cancer" (3 trials), "Metastatic Breast Cancer" (2 trials), "Multiple Myeloma" (2 trials) and "Onychomycosis" (2 trials). Many other conditions were trialed in "The Kirklin Clinic" in a lesser frequency.

Most popular intervention types in "The Kirklin Clinic" are "Drug" (45 trials), "Other" (10 trials), "Diagnostic Test" (3 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Ribavirin" (3 trials), "Apremilast" (2 trials), "BMS-986165" (2 trials) and "KRT-232" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Kirklin Clinic" are 43 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Kirklin Clinic". 2 are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in The Kirklin Clinic, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in The Kirklin Clinic, 5 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 7 trials that are defined as “Not Applicable".